• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学诱导的急性肝衰竭中间充质基质细胞依赖性免疫调节

Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure.

作者信息

Zhou Jia-Hang, Lu Xuan, Yan Cui-Lin, Sheng Xin-Yu, Cao Hong-Cui

机构信息

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China.

出版信息

World J Stem Cells. 2021 Mar 26;13(3):208-220. doi: 10.4252/wjsc.v13.i3.208.

DOI:10.4252/wjsc.v13.i3.208
PMID:33815670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8006015/
Abstract

Drug-induced liver injury (DILI), which refers to liver damage caused by a drug or its metabolites, has emerged as an important cause of acute liver failure (ALF) in recent years. Chemically-induced ALF in animal models mimics the pathology of DILI in humans; thus, these models are used to study the mechanism of potentially effective treatment strategies. Mesenchymal stromal cells (MSCs) possess immunomodulatory properties, and they alleviate acute liver injury and decrease the mortality of animals with chemically-induced ALF. Here, we summarize some of the existing research on the interaction between MSCs and immune cells, and discuss the possible mechanisms underlying the immuno-modulatory activity of MSCs in chemically-induced ALF. We conclude that MSCs can impact the phenotype and function of macrophages, as well as the differentiation and maturation of dendritic cells, and inhibit the proliferation and activation of T lymphocytes or B lymphocytes. MSCs also have immuno-modulatory effects on the production of cytokines, such as prostaglandin E2 and tumor necrosis factor-alpha-stimulated gene 6, in animal models. Thus, MSCs have significant benefits in the treatment of chemically-induced ALF by interacting with immune cells and they may be applied to DILI in humans in the near future.

摘要

药物性肝损伤(DILI)是指由药物或其代谢产物引起的肝损伤,近年来已成为急性肝衰竭(ALF)的重要原因。动物模型中化学诱导的ALF模拟了人类DILI的病理过程;因此,这些模型被用于研究潜在有效治疗策略的机制。间充质基质细胞(MSCs)具有免疫调节特性,可减轻急性肝损伤并降低化学诱导的ALF动物的死亡率。在此,我们总结了一些关于MSCs与免疫细胞相互作用的现有研究,并讨论了MSCs在化学诱导的ALF中免疫调节活性的潜在机制。我们得出结论,MSCs可影响巨噬细胞的表型和功能,以及树突状细胞的分化和成熟,并抑制T淋巴细胞或B淋巴细胞的增殖和激活。在动物模型中,MSCs对细胞因子如前列腺素E2和肿瘤坏死因子α刺激基因6的产生也具有免疫调节作用。因此,MSCs通过与免疫细胞相互作用在化学诱导的ALF治疗中具有显著益处,并且在不久的将来可能应用于人类DILI的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c70/8006015/5d1241ff183e/WJSC-13-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c70/8006015/7d3b5f043fea/WJSC-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c70/8006015/5d1241ff183e/WJSC-13-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c70/8006015/7d3b5f043fea/WJSC-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c70/8006015/5d1241ff183e/WJSC-13-208-g002.jpg

相似文献

1
Mesenchymal stromal cell-dependent immunoregulation in chemically-induced acute liver failure.化学诱导的急性肝衰竭中间充质基质细胞依赖性免疫调节
World J Stem Cells. 2021 Mar 26;13(3):208-220. doi: 10.4252/wjsc.v13.i3.208.
2
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review.间充质基质细胞(MSCs)及其外泌体在急性肝衰竭(ALF)中的作用:全面综述。
Stem Cell Res Ther. 2022 May 8;13(1):192. doi: 10.1186/s13287-022-02825-z.
3
Mesenchymal stromal cells promote liver regeneration through regulation of immune cells.间充质基质细胞通过调节免疫细胞促进肝脏再生。
Int J Biol Sci. 2020 Jan 22;16(5):893-903. doi: 10.7150/ijbs.39725. eCollection 2020.
4
Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.扁桃体来源的间充质干细胞缓解刀豆蛋白 A 诱导的急性肝损伤。
Exp Cell Res. 2014 Aug 1;326(1):143-54. doi: 10.1016/j.yexcr.2014.06.007. Epub 2014 Jun 19.
5
Porcine lung mesenchymal stromal cells possess differentiation and immunoregulatory properties.猪肺间充质基质细胞具有分化和免疫调节特性。
Stem Cell Res Ther. 2015 Nov 11;6:222. doi: 10.1186/s13287-015-0220-0.
6
Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.坏死性细胞死亡和T细胞免疫抑制是药物性肝损伤所致急性肝衰竭的特征。
Cytokine. 2016 Oct;86:21-28. doi: 10.1016/j.cyto.2016.07.010. Epub 2016 Jul 19.
7
Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure.间充质干细胞增加血红素加氧酶-1的表达,从而在急性肝衰竭治疗中产生抗炎活性。
Stem Cell Res Ther. 2017 Mar 20;8(1):70. doi: 10.1186/s13287-017-0524-3.
8
Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure.间充质干细胞增加血红素加氧酶 1 激活的自噬在急性肝衰竭治疗中的作用。
Biochem Biophys Res Commun. 2019 Jan 15;508(3):682-689. doi: 10.1016/j.bbrc.2018.11.146. Epub 2018 Dec 5.
9
Therapeutic effect of human umbilical cord blood mesenchymal stem cells combined with G-CSF on rats with acute liver failure.人脐带间充质干细胞联合 G-CSF 对急性肝衰竭大鼠的治疗作用。
Biochem Biophys Res Commun. 2019 Oct 1;517(4):670-676. doi: 10.1016/j.bbrc.2019.07.101. Epub 2019 Aug 7.
10
Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.间充质干细胞通过旁分泌肝细胞生长因子诱导树突状细胞免疫耐受,从而减轻急性肺损伤。
Stem Cell Res Ther. 2019 Dec 4;10(1):372. doi: 10.1186/s13287-019-1488-2.

引用本文的文献

1
Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure.间充质干细胞在治疗急性肝衰竭中的治疗潜力。
World J Gastroenterol. 2022 Jul 28;28(28):3627-3636. doi: 10.3748/wjg.v28.i28.3627.
2
Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review.间充质基质细胞(MSCs)及其外泌体在急性肝衰竭(ALF)中的作用:全面综述。
Stem Cell Res Ther. 2022 May 8;13(1):192. doi: 10.1186/s13287-022-02825-z.

本文引用的文献

1
Critical role of IL-1β in the pathogenesis of Agrocybe aegerita galectin-induced liver injury through recruiting T cell to liver.IL-1β 在灰树花凝集素诱导的肝损伤发病机制中的关键作用是通过招募 T 细胞到肝脏。
Biochem Biophys Res Commun. 2020 Jan 8;521(2):449-456. doi: 10.1016/j.bbrc.2019.10.087. Epub 2019 Oct 29.
2
Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis.间充质干细胞在化学性肝损伤中的免疫调节作用:一种高维分析。
Stem Cell Res Ther. 2019 Aug 23;10(1):262. doi: 10.1186/s13287-019-1379-6.
3
Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune mediated hepatitis and interrupts CD4+ T cells infiltration.
维甲酸调节免疫介导性肝炎中的 IL-4、IL-10 和 MCP-1 途径,并阻断 CD4+T 细胞浸润。
Int Immunopharmacol. 2019 Oct;75:105808. doi: 10.1016/j.intimp.2019.105808. Epub 2019 Aug 13.
4
MSC-triggered metabolomic alterations in liver-resident immune cells isolated from CCl-induced mouse ALI model.MSC 触发的 CCl4 诱导的小鼠 ALI 模型中分离的肝驻留免疫细胞的代谢组学改变。
Exp Cell Res. 2019 Oct 15;383(2):111511. doi: 10.1016/j.yexcr.2019.111511. Epub 2019 Jul 27.
5
Cell death in drug-induced liver injury.药物性肝损伤中的细胞死亡
Adv Pharmacol. 2019;85:31-74. doi: 10.1016/bs.apha.2019.01.006. Epub 2019 Feb 20.
6
Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure.改善间充质基质细胞及其衍生物治疗急性肝衰竭。
J Mol Med (Berl). 2019 Aug;97(8):1065-1084. doi: 10.1007/s00109-019-01804-x. Epub 2019 Jun 13.
7
Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models.与促炎巨噬细胞的细胞间接触增强了间充质干细胞在两种流产模型中的免疫治疗效果。
Cell Mol Immunol. 2019 Dec;16(12):908-920. doi: 10.1038/s41423-019-0204-6. Epub 2019 Feb 18.
8
Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment.间充质干细胞通过抑制中性粒细胞募集来减轻肝缺血/再灌注损伤。
J Immunol Res. 2018 Dec 3;2018:7283703. doi: 10.1155/2018/7283703. eCollection 2018.
9
Myths, reality and future of mesenchymal stem cell therapy.间质干细胞治疗的误区、现实与未来。
Cell Tissue Res. 2019 Mar;375(3):563-574. doi: 10.1007/s00441-018-2961-4. Epub 2018 Nov 20.
10
Human Fetal Liver Mesenchymal Stem Cell-Derived Exosomes Impair Natural Killer Cell Function.人胎肝间充质干细胞衍生的外泌体损害自然杀伤细胞功能。
Stem Cells Dev. 2019 Jan 1;28(1):44-55. doi: 10.1089/scd.2018.0015.